1
|
Alvi Z, Akhtar M, Mahmood A, Ur-Rahman N, Nazir I, Sadaquat H, Ijaz M, Syed SK, Waqas MK, Wang Y. Enhanced Oral Bioavailability of Epalrestat SBE 7-β-CD Complex Loaded Chitosan Nanoparticles: Preparation, Characterization and in-vivo Pharmacokinetic Evaluation. Int J Nanomedicine 2022; 16:8353-8373. [PMID: 35002232 PMCID: PMC8721161 DOI: 10.2147/ijn.s339857] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2021] [Accepted: 12/03/2021] [Indexed: 12/25/2022] Open
Abstract
Background Epalrestat (EPL) is a carboxylic acid derivative with poor aqueous solubility and its pharmacokinetic features are not fully defined. Purpose Current research aimed to fabricate inclusion complexation of EPL with SBE7 β-CD (IC) and EPL/SBE7 β-CD CS NPs (NP). Methods EPL was complexed with SBE7 β-CD using the co-precipitation method, and the prepared complex was fabricated into nanoparticles using the ionic gelation method. The prepared formulations were characterized for particle size analysis, surface morphology, and in vitro dissolution study. The % inhibition of EPL against α-glucosidase enzyme was also conducted to check the drug’s antidiabetic activity. Finally, an in vivo pharmacokinetic investigation was carried out to determine the concentration of EPL in rabbit plasma of the prepared formulation. In vivo pharmacokinetic studies were conducted by giving a single dose of pure EPL, IC, and NP. Results The size of NP was found to be 241.5 nm with PDI 0.363 and zeta potential of +31.8 mV. The surface of the prepared NP was non-porous, smooth and spherical when compared with pure EPL, SBE7 β-CD and IC. The cumulative drug release (%) from IC and NP was 73% and 88%, respectively, as compared to pure drug (25%). The % inhibition results for in vitro α-glucosidase was reported to be 74.1% and the predicted binding energy for in silico molecular docking was calculated to be −6.6 kcal/mol. The calculated Cmax values for EPL, IC and NP were 4.75±3.64, 66.91±7.58 and 84.27±6.91 μg/mL, respectively. The elimination half-life of EPL was 4 h and reduced to 2 h for IC and NP. The AUC0-α for EPL, IC and NP were 191.5±164.63, 1054.23±161.77 and 1072.5±159.54 μg/mL*h, respectively. Conclusion Taking these parameters into consideration it can be concluded that IC and NP have prospective applications for greatly improved delivery and regulatedt release of poorly water soluble drugs, potentially leading to increase therapeutic efficacy and fewer side effects.
Collapse
Affiliation(s)
- Zunaira Alvi
- Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan
| | - Muhammad Akhtar
- Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan.,Department of Medical Laboratory Technology, Faculty of Medicine and Allied Health Sciences, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan
| | - Arshad Mahmood
- College of Pharmacy, Al Ain University, Abu Dhabi Campus, Abu Dhabi, United Arab Emirates
| | - Nisar Ur-Rahman
- Department of Pharmacy, Royal College of Medical Sciences (RIMS), Multan, Punjab, 60000, Pakistan
| | - Imran Nazir
- Bahawal Victoria Hospital, Bahawalpur, Punjab, 63100, Pakistan
| | - Hadia Sadaquat
- Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan
| | - Muhammad Ijaz
- Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan
| | - Shahzada Khurram Syed
- Department of Basic Medical Sciences, School of Health Sciences, University of Management and Technology, Lahore, Pakistan
| | - Muhammad Khurram Waqas
- Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan
| | - Yi Wang
- Center for Advanced Low-Dimension Materials, State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201600, People's Republic of China
| |
Collapse
|
2
|
Yabré M, Ferey L, Somé TI, Mercier O, Gaudin K. Green reversed-phase HPLC development strategy: Application to artesunate and amodiaquine analysis. J Sep Sci 2020; 43:4390-4404. [PMID: 33058440 DOI: 10.1002/jssc.202000732] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Revised: 10/05/2020] [Accepted: 10/09/2020] [Indexed: 02/03/2023]
Abstract
A green analytical chemistry strategy is described to develop a reversed-phase high-performance liquid chromatography method for amodiaquine and artesunate analysis using ethanol-based mobile phases. This method development was particularly challenging due to the basicity of amodiaquine and low UV absorption of artesunate, leading to peak asymmetry and detection issues, respectively. UV detection concern was even more challenging due to the baseline drift observed with ethanol in gradient mode. Several green pH modifiers were selected for their ecofriendly character and their impact on peak shape and detection was investigated. The screening of various stationary phases (19 columns) appeared as a relevant and necessary approach to reach satisfactory peak shape of basic compounds. To support the results of this study, some additional compounds related to artesunate and amodiaquine structures were included. Methods were optimized and validated using total error approach with a mobile phase composed of ethanol and 10 mM formic acid using three different stationary phases from different manufacturers, providing flexibility of the quality control approach. Method greenness was assessed using the National Environmental Methods Index, the Green Analytical Procedure Index, and the Analytical Eco-Scale. Finally, artesunate and amodiaquine were successfully analyzed in fixed dose combination tablets.
Collapse
Affiliation(s)
- Moussa Yabré
- University Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux, F-33000, France.,Laboratoire de Toxicologie, Environnement et Santé (LATES), Université Jospeh Ki-Zerbo, 03 BP 7021, Burkina Faso
| | - Ludivine Ferey
- University Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux, F-33000, France
| | - Touridomon Issa Somé
- Laboratoire de Toxicologie, Environnement et Santé (LATES), Université Jospeh Ki-Zerbo, 03 BP 7021, Burkina Faso
| | | | - Karen Gaudin
- University Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux, F-33000, France
| |
Collapse
|
3
|
SERS-based trace-level quantification of sulindac: Spectroscopic and molecular modeling evaluation. J Mol Liq 2020. [DOI: 10.1016/j.molliq.2020.113402] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
4
|
Yabré M, Ferey L, Sakira AK, Bonmatin C, Fauré C, Somé TI, Gaudin K. Green Analytical Methods of Antimalarial Artemether-Lumefantrine Analysis for Falsification Detection Using a Low-Cost Handled NIR Spectrometer with DD-SIMCA and Drug Quantification by HPLC. Molecules 2020; 25:molecules25153397. [PMID: 32727052 PMCID: PMC7435840 DOI: 10.3390/molecules25153397] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 07/23/2020] [Accepted: 07/24/2020] [Indexed: 12/02/2022] Open
Abstract
Two green analytical approaches have been developed for the analysis of antimalarial fixed dose tablets of artemether and lumefantrine for quality control. The first approach consisted of investigating the qualitative performance of a low-cost handheld near-infrared spectrometer in combination with the principal component analysis as an exploratory tool to identify trends, similarities, and differences between pharmaceutical samples, before applying the data driven soft independent modeling of class analogy (DD-SIMCA) as a one-class classifier for proper drug falsification detection with 100% of both sensitivity and specificity in the studied cases. Despite its limited spectral range and low resolution, the handheld device allowed detecting falsified drugs with no active pharmaceutical ingredient and identifying specifically a pharmaceutical tablet brand name. The second approach was the quantitative analysis based on the green and fast RP-HPLC technique using ethanol as a green organic solvent and acetic acid as a green pH modifier. The optimal separation was achieved in 7 min using a mobile phase composed of ethanol 96% and 10 mM of acetic acid pH 3.35 (63:37, v/v). The developed method was validated according to the total error approach based on an accuracy profile, was applied to the analysis of tablets, and allowed confirming falsified drugs detected by spectroscopy.
Collapse
Affiliation(s)
- Moussa Yabré
- ChemBioPharm Team, ARNA Laboratory, INSERM U1212, CNRS UMR 5320, 146, Rue Léo Saignat, Bordeaux University, 33076 Bordeaux, France; (M.Y.); (L.F.); (C.B.); (C.F.)
- Laboratoire de Toxicologie, Environnement et Santé (LATES), Université Joseph Ki-Zerbo, Ouaga 03 BP 7021, Burkina Faso; (A.K.S.); (T.I.S.)
| | - Ludivine Ferey
- ChemBioPharm Team, ARNA Laboratory, INSERM U1212, CNRS UMR 5320, 146, Rue Léo Saignat, Bordeaux University, 33076 Bordeaux, France; (M.Y.); (L.F.); (C.B.); (C.F.)
| | - Abdoul Karim Sakira
- Laboratoire de Toxicologie, Environnement et Santé (LATES), Université Joseph Ki-Zerbo, Ouaga 03 BP 7021, Burkina Faso; (A.K.S.); (T.I.S.)
| | - Camille Bonmatin
- ChemBioPharm Team, ARNA Laboratory, INSERM U1212, CNRS UMR 5320, 146, Rue Léo Saignat, Bordeaux University, 33076 Bordeaux, France; (M.Y.); (L.F.); (C.B.); (C.F.)
| | - Clotilde Fauré
- ChemBioPharm Team, ARNA Laboratory, INSERM U1212, CNRS UMR 5320, 146, Rue Léo Saignat, Bordeaux University, 33076 Bordeaux, France; (M.Y.); (L.F.); (C.B.); (C.F.)
| | - Touridomon Issa Somé
- Laboratoire de Toxicologie, Environnement et Santé (LATES), Université Joseph Ki-Zerbo, Ouaga 03 BP 7021, Burkina Faso; (A.K.S.); (T.I.S.)
| | - Karen Gaudin
- ChemBioPharm Team, ARNA Laboratory, INSERM U1212, CNRS UMR 5320, 146, Rue Léo Saignat, Bordeaux University, 33076 Bordeaux, France; (M.Y.); (L.F.); (C.B.); (C.F.)
- Correspondence:
| |
Collapse
|
5
|
Kresge GA, Grosse S, Zimmer A, Grinias KM, De Pra M, Wong JMT, Steiner F, Grinias JP. Strategies in developing high-throughput liquid chromatography protocols for method qualification of pharmacopeial monographs. J Sep Sci 2020; 43:2964-2970. [PMID: 32388922 DOI: 10.1002/jssc.202000403] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 05/05/2020] [Accepted: 05/06/2020] [Indexed: 11/11/2022]
Abstract
Method qualification is a key step in the development of routine analytical monitoring of pharmaceutical products. However, when relying on published monographs that describe longer method times based on older high-performance liquid chromatography column and instrument technology, this can delay the overall analysis process for generated drug products. In this study, high-throughput ultrahigh pressure liquid chromatography techniques were implemented to decrease the amount of time needed to complete a 24-run sequence to identify linearity, recovery, and repeatability for both drug assay and impurity analysis in 16 min. Multiple experimental parameters were tested to identify a range of experimental settings that could be used for the sequence while still maintaining this fast analysis time. The full sequence was replicated on a different system and with different columns, further demonstrating its robustness.
Collapse
Affiliation(s)
- Glenn A Kresge
- Department of Chemistry & Biochemistry, Rowan University, Glassboro, NJ, USA
| | | | - Alexis Zimmer
- Department of Chemistry & Biochemistry, Rowan University, Glassboro, NJ, USA
| | - Kaitlin M Grinias
- Analytical Platforms & Platform Modernization , GlaxoSmithKline, Collegeville, PA, USA
| | | | | | | | - James P Grinias
- Department of Chemistry & Biochemistry, Rowan University, Glassboro, NJ, USA
| |
Collapse
|
6
|
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma. Ther Drug Monit 2017. [DOI: 10.1097/ftd.0000000000000428] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Patel MN, Kothari CS. Review on Implementation of Multivariate Approach for Forced Degradation Study and Impurity Profiling with Regulatory Considerations. Chromatographia 2017. [DOI: 10.1007/s10337-017-3393-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
8
|
Panda SS, Ravi Kumar VVB, Beg S, Sahu SK, Muni S. Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Estimating Vilazodone Hydrochloride in Pharmaceutical Dosage Form Using Quality by Design. J Chromatogr Sci 2016; 54:1713-1722. [DOI: 10.1093/chromsci/bmw127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2015] [Revised: 05/24/2016] [Indexed: 11/13/2022]
|
9
|
Panda SS, Bera VVRK, Beg S, Sahu SK. Ultrafast Liquid Chromatographic Method Development and its Validation for Quantification of Telaprevir in Pharmaceutical Dosage Form by Using Quality by Design Approach. J Chromatogr Sci 2015; 53:1193-202. [DOI: 10.1093/chromsci/bmu228] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2014] [Indexed: 11/14/2022]
|
10
|
Preparation and characterization of a sulindac sensor based on PVC/TOA–SUL membrane. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2014; 37:383-9. [DOI: 10.1016/j.msec.2014.01.030] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2013] [Revised: 12/09/2013] [Accepted: 01/18/2014] [Indexed: 11/21/2022]
|
11
|
Forced degradation and impurity profiling: Recent trends in analytical perspectives. J Pharm Biomed Anal 2013; 86:11-35. [DOI: 10.1016/j.jpba.2013.07.013] [Citation(s) in RCA: 100] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2013] [Revised: 06/28/2013] [Accepted: 07/07/2013] [Indexed: 11/23/2022]
|
12
|
Gumustas M, Kurbanoglu S, Uslu B, Ozkan SA. UPLC versus HPLC on Drug Analysis: Advantageous, Applications and Their Validation Parameters. Chromatographia 2013. [DOI: 10.1007/s10337-013-2477-8] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
13
|
|
14
|
Cózar-Bernal M, Rabasco A, González-Rodríguez M. Development and validation of a high performance chromatographic method for determining sumatriptan in niosomes. J Pharm Biomed Anal 2013; 72:251-60. [DOI: 10.1016/j.jpba.2012.08.030] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2012] [Revised: 08/23/2012] [Accepted: 08/31/2012] [Indexed: 11/16/2022]
|
15
|
Experimental design in chromatography: A tutorial review. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 910:2-13. [DOI: 10.1016/j.jchromb.2012.01.020] [Citation(s) in RCA: 292] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2011] [Revised: 01/03/2012] [Accepted: 01/19/2012] [Indexed: 12/15/2022]
|
16
|
Dispas A, Lebrun P, Sassiat P, Ziemons E, Thiébaut D, Vial J, Hubert P. Innovative green supercritical fluid chromatography development for the determination of polar compounds. J Chromatogr A 2012; 1256:253-60. [DOI: 10.1016/j.chroma.2012.07.043] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2012] [Revised: 07/13/2012] [Accepted: 07/16/2012] [Indexed: 11/26/2022]
|
17
|
Debrus B, Lebrun P, Kindenge JM, Lecomte F, Ceccato A, Caliaro G, Mbay JMT, Boulanger B, Marini R, Rozet E, Hubert P. Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space. J Chromatogr A 2011; 1218:5205-15. [DOI: 10.1016/j.chroma.2011.05.102] [Citation(s) in RCA: 79] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2011] [Revised: 05/30/2011] [Accepted: 05/30/2011] [Indexed: 11/15/2022]
|